How Much Blood Can You Lose Before Shock

Crit Care. 2004; 8(five): 373–381.

Clinical review: Hemorrhagic daze

Guillermo Gutierrez

¹Professor, Pulmonary and Critical Care Medicine Division, Department of Medicine, The George Washington University Medical Center, Washington, Commune of Columbia, United states of america

H David Reines

^twoProfessor, Virginia Commonwealth University and Vice-Chairman, Section of Surgery, Inova Fairfax Hospital, Falls Church, Virginia, The states

Marian E Wulf-Gutierrez

³Associate Professor, Department of Obstetrics and Gynecology, The George Washington Academy, Inova Fairfax Hospital, Falls Church, Virginia, USA

Abstruse

This review addresses the pathophysiology and handling of hemorrhagic shock – a condition produced by rapid and significant loss of intravascular volume, which may lead sequentially to hemodynamic instability, decreases in oxygen delivery, decreased tissue perfusion, cellular hypoxia, organ harm, and death. Hemorrhagic shock can be speedily fatal. The primary goals are to stop the bleeding and to restore circulating blood volume. Resuscitation may well depend on the estimated severity of hemorrhage. It now appears that patients with moderate hypotension from haemorrhage may do good by delaying massive fluid resuscitation until they reach a definitive care facility. On the other manus, the utilise of intravenous fluids, crystalloids or colloids, and blood products tin be life saving in those patients who are in severe hemorrhagic stupor. The optimal method of resuscitation has non been clearly established. A hemoglobin level of seven–8 g/dl appears to be an appropriate threshold for transfusion in critically ill patients with no prove of tissue hypoxia. However, maintaining a higher hemoglobin level of ten yard/dl is a reasonable goal in actively bleeding patients, the elderly, or individuals who are at risk for myocardial infarction. Moreover, hemoglobin concentration should not be the just therapeutic guide in actively bleeding patients. Instead, therapy should exist aimed at restoring intravascular volume and acceptable hemodynamic parameters.

Keywords: claret loss, estimated claret book, hemorrhage, oxygen consumption, oxygen delivery, shock, transfusion

Introduction

Life-threatening decreases in blood pressure often are associated with a state of shock – a condition in which tissue perfusion is not capable of sustaining aerobic metabolism. Daze can exist produced by decreases in cardiac output (cardiogenic), past sepsis (distributive), or by decreases in intravascular volume (hypovolemic). The latter may be caused past aridity from vomiting or diarrhea, by severe environmental fluid losses, or by rapid and substantial loss of blood. A less common grade of shock (cytopathic) may occur when the mitochondria are incapable of producing the free energy required to sustain cellular function [ane]. Agents that interfere with oxidative phosphorylation, such every bit cyanide, carbon monoxide and rotenone, can produce this blazon of shock.

Hemorrhage is a medical emergency that is often encountered by physicians in emergency rooms, operating rooms, and intensive care units. Meaning loss of intravascular book may lead sequentially to hemodynamic instability, decreased tissue perfusion, cellular hypoxia, organ harm, and death. This review addresses the pathophysiology and treatment of hypovolemic daze produced by hemorrhage, which is also known as hemorrhagic shock.

Physiologic considerations in hemorrhagic stupor

Estimating blood loss

The boilerplate adult blood volume represents 7% of body weight (or lxx ml/kg of trunk weight) [2]. Estimated blood book (EBV) for a lxx kg person is approximately v l. Blood volume varies with age and physiologic country. When indexed to body weight, older individuals have a smaller blood book. Children take EBVs of eight–9% of body weight, with infants having an EBV as high as ix–10% of their full body weight [three].

Estimating blood loss is complicated by several factors, including urinary losses and the development of tissue edema. To help guide volume replacement, hemorrhage tin can be divided into four classes (Tabular array ​ 1). Class I is a nonshock state, such equally occurs when altruistic a unit of claret, whereas class Four is a preterminal event requiring firsthand therapy [4]. Massive hemorrhage may be divers as loss of total EBV within a 24-hour period, or loss of half of the EBV in a 3-60 minutes period.

Table ane

Classification of hemorrhage

	Class
Parameter	I	II	III	4
Blood loss (ml)	<750	750–1500	1500–2000	>2000
Claret loss (%)	<15%	15–xxx%	xxx–40%	>twoscore%
Pulse rate (beats/min)	<100	>100	>120	>140
Blood pressure	Normal	Decreased	Decreased	Decreased
Respiratory rate (breaths/min)	14–20	xx–30	xxx–40	>35
Urine output (ml/hr)	>thirty	20–30	five–fifteen	Negligible
CNS symptoms	Normal	Anxious	Confused	Lethargic

Modified from Committee on Trauma [iv]. CNS = central nervous system.

A relatively simple way to gauge acute blood loss is past considering the intravascular space equally a unmarried compartment, in which hemoglobin changes co-ordinate to the caste of blood loss and fluid replacement (Fig. ​ ane). When book losses are non replaced during hemorrhage, hemoglobin concentration will remain constant. In that condition a rough estimate of claret loss may be obtained using the classification provided in Tabular array ​ i. Conversely, when blood losses are sequentially replaced past isovolemic fluid infusion, the estimated blood loss may be obtained as follows [5]:

One compartment model of the vascular space.

EBL = EBV × ln(H_i/H_f)

Where H_i and H_f announce the initial and final hematocrit. Implicit in this equation is the absence of significant urinary losses or the leakage of intravascular fluid into the tissues. For example, a subtract in hematocrit from 40% to 26% with complete fluid replacement of blood losses corresponds to an estimated blood loss of 2.1 fifty.

Intravenous fluid infusion in the absence of bleeding also will lower hemoglobin concentration. Using the ane-compartment model, a offset approximation to hemodilution with intravenous fluids is as follows:

H_f = EBV × H_i/(EBV + volume infused)

This is the lowest possible guess of H_f, because fluid administration and expansion of intravascular fluid volume will trigger compensatory mechanisms to increment glomerular filtration rate and decrease plasma book.

Transfusing packed scarlet cells in a person who is not actively haemorrhage will increase hemoglobin concentration by 1 g/dl (or iii% hematocrit) per unit of packed red blood prison cell transfused. It is impossible to judge the effect of blood transfusion on volume or hemoglobin concentration in actively bleeding individuals. Measures of central venous or, preferably, pulmonary artery pressures are needed to estimate the caste of fluid replacement that may be required.

Alterations in systemic oxygen delivery during hemorrhagic stupor

Decreases in circulating blood volume during severe hemorrhage can depress cardiac output and lower organ perfusion force per unit area. Severe hemorrhage impairs the delivery of oxygen and nutrients to the tissues and produces a state of shock. A clearer agreement of the pathophysiology of hemorrhagic daze may be obtained by defining the process of oxygen commitment and utilization by the tissues. Total oxygen delivery (DO ₂ [mlO₂/min per grandⁱⁱ]) is the product of cardiac alphabetize (50/min per 1000ⁱⁱ) and arterial oxygen content (CaO ₂ [mlO₂/fifty blood]). CaO ₂ is calculated equally 13.iv × [Hb] × SaO _ii + 0.03 PaO ₂, where [Hb] represents the concentration of hemoglobin in blood (m/dl), SaO _two is the hemoglobin oxygen saturation and PaO ₂ is the partial pressure of oxygen in arterial claret.

Under normal aerobic conditions, systemic oxygen consumption (VO ₂) is proportional to the metabolic rate and varies according to the body'south free energy needs. VO ₂ may be calculated using Fick's principle as the departure between the rates of oxygen delivered and oxygen leaving the tissues: 5O ₂ = cardiac alphabetize × (CaO _ii - CmvO ₂), where C_mvO₂ is the oxygen content of mixed venous blood. Calculation of VO ₂ using Fick'southward equation does non account for pulmonary oxygen consumption, which may be substantial during astute lung injury [6].

Another useful parameter when defining tissue oxygenation is the fraction of oxygen consumed to oxygen delivered to the tissues, termed the oxygen extraction ratio and calculated as (CaO _ii - CmvO ₂)/CaO _two.

The human relationship of oxygen commitment to oxygen consumption during hemorrhagic shock

Rapid decreases in blood book may lead to decreases in cardiac output and in DO _ii with footling change in VO _two, because blood flow is preferentially distributed to tissues with greater metabolic requirements. Increased efficiency in oxygen utilization during hypoxia is reflected by a ascent in oxygen extraction ratio [7]. Lowering regional vascular resistance by adenosine, prostaglandins, and nitric oxide induces hypoxic redistribution of blood period [8,9]. In spite of this organ-specific microvascular response, all organs, with the possible exception of the heart, feel decreases in claret flow during severe hypovolemia [10].

Another targeted response to hemorrhage is an increment in the number of open up capillaries in organs that are capable of this. For example, in skeletal musculus only a fraction of capillaries are commonly open up to suit the passage of erythrocytes whereas the remaining capillaries allow only passage of plasma [11]. During hemorrhage the number of open capillaries increases in proportion to the degree of tissue hypoxia [12]. Capillary recruitment shortens the improvidence distance from red claret cells to the surrounding tissue [thirteen] and increases the capillary surface surface area bachelor for oxygen diffusion [14]. The overall effect of capillary recruitment is the maintenance of tissue oxygen flux at a lower capillary oxygen tension, which is a vital response in organs on the border of hypoxia.

Astringent and sustained decreases in DO ₂ eventually overwhelm the microvascular responses to hypoxia. As tissue oxygen flux falters, mitochondria cannot sustain aerobic metabolism and 5O _two decreases. The rate of DO ₂ associated with the initial turn down in FiveO ₂ is defined equally the critical DO ₂ (DO _2crit) [15]. Animal experiments prove that DO _2crit is a remarkably abiding parameter regardless of the method used to decrease DO ₂, be it anemia, hypoxemia, or hypovolemia [16].

Hypovolemia and isovolemic anemia

Patients with massive hemorrhage may experience conditions ranging from severe hypovolemia, in which claret volume decreases with no changes in hemoglobin concentration, to isovolemic anemia, in which extreme decreases in hemoglobin concentration occur with normal or even increased blood book.

Hypovolemia occurs in quickly haemorrhage individuals who are non receiving intravenous fluids. The importance of circulating blood volume has been demonstrated in animals subjected to the sequential removal of blood aliquots from a key vein [17]. These experiments bear witness that 5O ₂ remains constant as the circulating blood volume decreases. FiveO ₂ falls precipitously and death speedily ensues below a DO _2crit of 8–10 mlO₂/min per kg. At this disquisitional juncture, decreases in blood volume arroyo 50% with no changes in hemoglobin concentration. Hypovolemia is associated with substantial decreases in cardiac output and mixed venous oxygen tension.

Aggressive fluid replacement may produce the condition of isovolemic anemia, which is characterized by adequate blood volume but decreased hemoglobin concentration and low oxygen carrying chapters. Isovolemic anemia occurs when blood for transfusion is not readily available or in individuals who are haemorrhage but refuse to take claret products. Experimental isovolemic anemia is produced by drawing blood aliquots from a fundamental vein and replacing the exact amount of blood removed with a colloidal solution such equally albumin. Animals subjected to progressive isovolemic anemia also exhibit a DO _2crit in the neighborhood of x mlO₂/min per kg [18]. Do_2crit is reached at a hemoglobin concentration of approximately four.0 g/dl (corresponding to a hematocrit <8%). Isovolemic anemia is associated with increased cardiac output and greater mixed venous oxygen tensions than those noted for hypovolemia or hypoxemia [nineteen].

Individuals with chronic isovolemic anemia, such as those with renal failure, tolerate decreases in hemoglobin to levels of vi–7 thousand/dl. In fact, astute hemodilution did non produce tissue hypoxia in salubrious human being volunteers who had their blood hemoglobin concentration reduced to 5.0 g/dl [twenty]. Acute isovolemic hemodilution decreased systemic vascular resistance and increased heart rate, stroke volume, and cardiac index, but there were no changes in VO _ii or in plasma lactate. In a subsequent report conducted in resting volunteers, hemoglobin concentration was lowered by isovolemic anemia to four.eight g/dl, decreasing DO ₂ to 7.3 mlO₂/min per kg without evidence of inadequate systemic oxygenation [21].

Cellular responses to acute blood loss

Compensated shock occurs when systemic DO ₂ decreases below DO _2crit and the tissues turn to anaerobic sources of energy. Under these conditions, cellular role is maintained as long as the combined yield of aerobic and anaerobic sources of energy provides sufficient ATP for protein synthesis and contractile processes. Some tissues are more resistant to hypoxia than others. Skeletal and smooth muscles are highly resistant to hypoxia [22,23] and irreversible damage does not occur in isolated hepatocytes until 2.v hours of ischemia [24]. Conversely, brain cells sustain permanent damage after but a few minutes of hypoxia [25]. The gut appears to be especially sensitive to decreases in perfusion. The abdominal and gastric mucosa show prove of anaerobic metabolism before decreases in systemic VO ₂ are detected [26].

Uncompensated daze resulting in irreversible tissue impairment occurs when the combined aerobic and anaerobic supplies of ATP are not sufficient to maintain cellular role (Fig. ​ 2). Failure of membrane-associated ion ship pumps, in item those associated with the regulation of calcium and sodium, results in the loss of membrane integrity and in cellular swelling [27,28]. Among other mechanisms that lead to irreversible cellular injury during hypoxia are depletion of cellular free energy, cellular acidosis, oxygen free radical generation, and loss of adenine nucleotides from the cell [29].

Changes in oxygen consumption shown as a function of oxygen delivery. Too shown are the hypothetical relationships of these parameters to the stages of hemorrhage (Table ​ ane) and changes in cellular membrane integrity. DO _2crit, critical oxygen commitment.

Systemic responses to acute blood loss

The first response to claret loss is an attempt to form a jell at the local site of hemorrhage. Equally hemorrhage progresses, catecholamines, antidiuretic hormone, and atrial natriuretic receptors respond to the perceived loss of volume by vasoconstriction of arterioles and muscular arteries and by increasing the heart rate. The aim of these compensatory mechanisms is to increase cardiac output and maintain perfusion pressure. Urine output drops somewhat and thirst is stimulated to maintain circulating blood book.

Anxiety may exist related to the release of catecholamines and to balmy decreases in cerebral blood period. A person who is bleeding briskly also may develop tachypnea and hypotension. Every bit hypovolemia worsens and tissue hypoxia ensues, increases in ventilation compensate for the metabolic acidosis produced by increased carbon dioxide production. Compensatory mechanisms are eventually overwhelmed past volume losses, and blood flow to the renal and splanchnic vasculature decreases and systolic blood pressure declines. The loss of coronary perfusion pressure adversely affects myocardial contractility; cerebral claret flow decreases, resulting in the loss of consciousness, coma, and eventually death.

Clinical considerations in hemorrhagic shock

The therapeutic goals for hemorrhagic daze are to stop bleeding and to restore intravascular book. This review does not address methods of stopping hemorrhage, but rather deals with the physiologic and pathologic derangements produced by severe hemorrhage and how all-time to care for them.

Clinical manifestations

Shock is a state of hypoperfusion associated with hemodynamic abnormalities leading to the collapse of homeostasis, or as poetically stated by John Collins Warren, a 'momentary pause in the act of death' [xxx]. The etiology of shock in traumatized patients is likely to be massive blood loss simply other causes of daze must be considered. These include blunt myocardial damage, spinal cord injury, tension pneumothorax, or pericardial tamponade.

Not all trauma patients with tissue hypoperfusion as the result of massive hemorrhage arrive at the emergency department with signs of shock. The lack of a specific diagnosis should not delay resuscitation from severe hypovolemia when hemorrhage is suggested by history, physical exam, or laboratory findings.

A rapid assessment of the possible source of bleeding is essential when acute hemorrhage is the suspected cause for hemodynamic instability, and a thorough physical examination should be performed. Emergency personnel may requite an estimate of claret loss at the scene, merely ane should always be wary of such estimates considering they are notoriously inaccurate. In general, young patients who present with tachycardia and balmy hypotension are in danger of losing their compensatory mechanisms and may well slip into profound shock unless vigorous therapy is initiated. Reliance on systolic blood pressure alone may delay recognition of the shock state. Most practitioners tin palpate a carotid pulse in an adult. This is equivalent to a systolic pressure of 60 mmHg. A femoral pulse is produced by a systolic pressure of 60–70 mmHg. A palpable radial pulse ordinarily requires slightly higher pressures.

Gastrointestinal haemorrhage and trauma are the most common causes of hemorrhage. Other causes of hemorrhagic daze include ruptured abdominal aortic aneurysms, spontaneous haemorrhage from anticoagulation, and postpartum bleeding secondary to a placenta previa or placenta abruption (Table ​ 2). A ruptured ectopic pregnancy or a ruptured ovarian cyst also tin cause hemorrhagic shock without an obvious source of claret loss [31]. The evaluation of shock in a adult female of childbearing age should include a pregnancy examination and perchance a culdocentesis. Stopping the haemorrhage, as well as replacing the claret volume, is the treatment for shock resulting from postpartum hemorrhage.

Table 2

Common causes of hemorrhagic shock

Crusade	Examples (where applicable)
Antithrombotic therapy
Coagulopathies
Gastrointestinal bleeding	Esophageal varices
	Esophagogastric mucosal tear (Mallory–Weiss)
	Gastritis
	Gastric and duodenal ulcerations
	Gastric and esophageal cancer
	Colon cancer
	Colonic diverticula
Obstetric/gynecologic	Placenta previa
	Abruptio placentae
	Ruptured ectopic pregnancy
	Ruptured ovarian cyst
Pulmonary	Pulmonary embolus
	Lung cancer
	Cavitary lung disease: tuberculosis, aspergillosis
	Goodpasture'south syndrome
Ruptured aneurysms
Retroperitoneal haemorrhage
Trauma	Lacerations
	Penetrating wounds to the abdomen and breast
	Ruptured major vessels

Blood losses from external lacerations are hard to approximate but usually respond to direct pressure and book resuscitation. Intrathoracic injuries, especially to the lung, center, or the great vessels, can event in the loss of several liters of blood into the thorax without external show of hemorrhage. Intra-abdominal injuries to solid organs (spleen and liver) and not bad vessels (ruptured aneurysm, penetrating injury to intra-abdominal vessels) can crusade rapid loss of the unabridged blood book into the abdomen. Massive bleeding into the gastrointestinal tract from ulcers or abdominal diverticuli tin can as well cause shock, but the patient unremarkably manifests either hematochezia or hematemesis when blood loss is rapid and acute.

Fractures of the pelvis can hibernate massive amounts of haemorrhage with trivial external evidence [32]. An unstable pelvis on physical examination always raises the possibility of significant blood loss. Spontaneous bleeding into the retroperitoneum tin also cause shock without significant physical findings. Fractures of the lower extremities, especially closed femur fractures, tin easily hibernate 2–3 units of blood, whereas open fractures can lacerate major vessels and cause meaning blood loss. Head injury is rarely a cause of hypotension and is never the cause of massive blood loss, unless there is external haemorrhage.

Treatment of hemorrhagic shock

The chief goals of resuscitation are to stop the source of hemorrhage and to restore circulating claret volume. Actively bleeding patients should have their intravascular fluid replaced considering tissue oxygenation volition non be compromised, even at low hemoglobin concentrations, as long every bit circulating volume is maintained. Hemoglobin concentration in an actively bleeding private has dubious diagnostic value considering information technology takes fourth dimension for the various intravascular compartments to equilibrate. Rather, therapy should exist guided by the rate of bleeding and changes in hemodynamic parameters, such every bit claret force per unit area, heart rate, cardiac output, central venous pressure, pulmonary artery wedge pressure, and mixed venous saturation.

Restoration of the intravascular fluid volume

Since the time of Globe War 2, the accepted therapeutic dogma has been to restore blood volume apace and achieve normal physiologic parameters. Generations of physicians have been trained to reverse shock within the 'gilt hour' in order to preserve organ function and preclude expiry.

Every bit early as 1918, however, Cannon and coworkers [33] questioned the feasibility of restoring blood pressure back to normal in the face of active hemorrhage. Wiggers [34] proposed the concept of 'irreversible daze' later on showing that reinfusing blood into a profoundly shocked animal was not sufficient to forbid mortality and morbidity. Later on, Shires and coworkers [35] demonstrated in experimental preparations that crystalloid fluids were needed in add-on to blood to restore perfusion. They were able to demonstrate failure of the sodium–potassium pump, resulting in the ingress of sodium and h2o into the cells. The sensation of 'tertiary space losses' into the interstitium and tissues resulted in the 'three-to-one' rule for resuscitation: that is, 3 ml of crystalloid (Ringers lactate or normal saline) for every i ml of claret loss replaced.

Four issues should be considered when treating hemorrhagic daze: type of fluid to give, how much, how fast, and what the therapeutic end-points are. The platonic fluid for resuscitation has not been established. The three-to-one rule has been applied to the classification of hemorrhage to constitute a baseline for guiding therapy [36], and use of crystalloid (Ringers lactate or normal saline) is recommended by the American Higher of Surgeons [four]. Although resuscitative finish-points are similar when using Ringers lactate or normal saline, metabolic hyperchloremic acidosis has been reported when infusing large volumes of normal saline (>10 fifty) [35].

Colloidal solutions, such as albumin and hetastarch (half-dozen% hydroxyethyl starch in 0.ix% NaCl), can exist administered to increment circulatory volume speedily. Although it is beyond the telescopic of this review to enter the crystalloid versus colloid fray, we should note that the utilize of albumin solutions in the initial resuscitation stages has not proven to be more effective than crystalloid [37-39]. A meta-analysis of 26 prospective randomized trials (including a total of 1622 patients) revealed an increased absolute risk for death of 4% when colloids were used for resuscitation [forty]. The results of this meta-analysis sparked a groovy deal of controversy on the use of albumin as a replacement fluid. The conclusions of these analyses should be viewed with caution considering the inclusion criteria for the various studies included in the meta-analyses differed. It should be noted, however, that the American College of Surgeons does recommend the apply of albumin as a resuscitative fluid [4].

Hypertonic saline

In that location is continuing interest in the role of hypertonic saline during resuscitation from hypovolemic stupor. There is some show that the apply of hypertonic saline in traumatized patients with closed caput injury may be efficacious [41], but this is controversial and the Usa Nutrient and Drug Administration has not given approval for its use during the resuscitation of patients. A prospective, randomized report comparing hypertonic saline with dextran establish no deviation in survival between the hypertonic saline grouping and the dextran-treated group [42]. Modest volume hypertonic saline does hold some promise in cases of penetrating trauma [43].

Blood substitutes

Claret substitutes have been tried in many forms [44]. A report past Gould and colleagues [45] on the effect of massive doses of hemoglobin solutions in hemorrhagic trauma patients demonstrated a possible benefit when compared with infusion of crystalloids. In that study, 171 patients received rapid infusion of one–20 units of poly-HEME (Sigma, St. Louis, MO, United states; human polymerized hemoglobin) in lieu of homo blood. Bloodshed was 25%, every bit compared with 64% for historical matched control individuals. On the other hand, the sobering results of a randomized, prospective, multicenter written report conducted past Sloan and coworkers [46], in which traumatic hemorrhagic shock patients were treated with diaspirin cross-linked hemoglobin, volition remain an impediment to farther inquiry in this area for many years to come. At 28 days, 24 (46%) of the 52 patients infused with diaspirin cross-linked hemoglobin died compared with eight (17%) of the 46 patients infused with a saline solution (P = 0.003).

When to transfuse

The utilize of claret and claret products is necessary when the estimated claret loss from hemorrhage exceeds 30% of the blood volume (class III hemorrhage). Determining this point has been extremely difficult during an acute hemorrhage considering of hemodilution produced past fluid resuscitation. As mentioned previously, whereas formulas have been proposed to estimate blood losses, the use of blood as a resuscitative fluid is empirical [5,47].

Presently, a hypotensive patient who fails to reply to ii fifty crystalloid in the face up of likely hemorrhage should be treated with blood and blood products. O-negative blood for women and O-positive for men is infused if type and cross-matched blood is not hands available. Claret transfusions take several negative side effects and have been associated with worse consequence in patients with trauma [48]. Amongst the complications of blood transfusion are decreased immunity and increased rate of infection, as well every bit bug associated with transmissible diseases and improper assistants [49,50].

Transfusion in the critically ill patient

Several national organizations in the USA and Canada have issued guidelines for claret transfusion. These include the consensus conferences of the National Institutes of Health [51], the American College of Physicians [52], the American Society of Anesthesiology [53], and the Canadian Medical Association [54]. These guidelines recommend a hemoglobin level between 6 and viii one thousand/dl every bit a threshold for transfusion in patients without known risk factors. They also agree in their disapproval of safe blood transfusion, because patients with hemoglobin levels greater than 10 g/dl are unlikely to benefit from blood transfusion. These guidelines have rapidly been incorporated into the everyday practice of medicine, leading some to question whether claret transfusion is at present nether-used [55].

When it comes to high hazard or critically ill patients, clinical evidence in support of transfusion guidelines is more hard to obtain and therapy has frequently been guided by clinical judgment. A written report of transfusion practices in Canada noted that 28% of patients admitted to third level intensive intendance units received cherry jail cell transfusions [56]. The most frequent reason for administering cerise cells was non the patient's hemoglobin concentration. Instead, blood transfusions were ordered if patients were acutely bleeding (35% of patients transfused) or in gild to increase DO ₂ (25% of patients transfused).

A multi-institutional, prospective, randomized study was conducted to determine whether a restrictive strategy of red cell transfusion and a liberal strategy produced equivalent results in critically sick patients [57]. Patients were enrolled in the study within 72 hours of access to the intensive care unit if their hemoglobin concentrations was below ix g/dl. Patients were randomly assigned either to a liberal strategy of transfusion (n = 420), in which hemoglobin values were maintained at a level between ten and 12 g/dl, or to a restrictive strategy of transfusion, in which hemoglobin values were maintained between 7 and ix thou/dl (n = 418). Mortality at 30 days was similar for the two groups (nineteen% versus 23%). Subgroup analysis showed that mortality rates were lower with the restrictive transfusion strategy amid less acutely ill patients and amidst those nether 55 years old. Furthermore, the bloodshed rate during hospitalization was significantly lower in the restrictive strategy group (22% versus 28%). These data suggest that a restrictive strategy of crimson cell transfusion in critically ill patients is at least as effective as a liberal transfusion strategy. Moreover, a prospective observational study of 1136 patients conducted in Europe showed an clan between transfusions and decreased organ office and increased mortality [58].

Transfusion in elderly patients

Tolerance of anemia is dependent on the recruitment of physiologic reserve, mainly past increasing cardiac output. Low levels of hemoglobin that are tolerated by younger patients may be deleterious in the elderly. Reserve mechanisms in the elderly may be blunted with avant-garde historic period and the presence of coronary avenue stenosis. This likewise may explain why elderly patients with acute myocardial infarction are at extremely loftier risk for death despite having infarct sizes similar to those in younger patients.

A study conducted by Wu and coworkers [59] indicated that a substantial number of people who present to the hospital with acute myocardial infarction and a hematocrit of 24% or lower may benefit from blood transfusion. In a retrospective analysis of data from 78,974 patients aged 65 years or older and who were hospitalized with acute myocardial infarction, those with lower hematocrit values (<24%) on admission had higher 30-twenty-four hour period mortality rates. Claret transfusion was associated with a reduction in 30-day mortality amidst patients whose hematocrit on admission was in the 5–24% range. Blood transfusion did non ameliorate survival among those whose hematocrit values fell in the college ranges.

Delayed versus immediate resuscitation

Recent data question the practice of initial aggressive resuscitation of hemorrhagic shock. Cannon and coworkers [33] raised the business concern that raising blood pressure in a haemorrhage patient would eliminate the clot and increment bleeding. This theory was replaced in Earth War 2 and in Vietnam by the concept that restoration of blood volume as presently as possible was the key to survival. The concept of the 'gold 60 minutes' as the time period allowed for medical personnel to contrary shock and prevent organ organisation damage has dominated the thinking of trauma surgeons for a generation.

Bickell and coworkers [sixty] challenged this approach when they performed a randomized prospective study of patients with penetrating truncal injuries who were hypotensive in the field (systolic claret pressure <xc mmHg). Patients were randomized according to the solar day of the calendar month to receive either standard resuscitation with Ringers lactate or placement of intravenous catheters without intravenous fluid assistants. Patients were excluded if they had cardiopulmonary collapse in the field, astringent head injury, or did not need surgical intervention. A total of 598 matched control patients were included in the study grouping. The immediate resuscitation group received an average of 900 ml fluid before hospitalization compared with 100 ml fluid in the delayed resuscitation grouping. Of the delayed resuscitation group 70% were discharged, as compared with 62% of the firsthand fluid grouping (P = 0.04), and the delayed grouping trended to accept fewer complications.

Animal information demonstrate a reduced gamble for death with fluid resuscitation in severe hemorrhage. On the other hand, a systematic review of the brute studies besides showed an increased risk for death from aggressive resuscitation in animals with less severe hemorrhage [61]. This finding suggests that excessive fluid resuscitation can be lethal when severe hemorrhage is not present. Another report [62] found no differences in survival in patients presenting in hemorrhagic shock treated with 2 fluid replacement protocols, 1 that required fluid replacement to a systolic blood pressure level in backlog of 100 mmHg (conventional) and another that required fluid replacement to a systolic blood pressure in excess of 70 mmHg.

Whether or not 1 fully resuscitates a bleeding patient depends on the rate of haemorrhage, the ability to control the bleeding, and the presence of coagulopathy. It may be that excessive fluid resuscitation before surgical hemostasis will be accompanied by increased bleeding that may ultimately touch mortality. Although some actively bleeding patients volition exsanguinate immediately, others will stop bleeding spontaneously. Fluid resuscitation should be focused on injuries that volition not undergo spontaneous hemostasis [63]. The challenge lies in identifying those patients.

End-points in resuscitation

Defining the end-points of resuscitation is also a difficult area of study. Up to 85% of patients are nether-resuscitated when using blood force per unit area and urine output as the sole guides to fluid replacement [64]. The trouble may exist 'compensated shock', in which cellular perfusion lags behind gross physiologic parameters. Other stop-points, such as oxygen transport variables, DO ₂, cardiac alphabetize, VO _two, lactate, base of operations deficit, and mucosal gastric pH, are all more sensitive endpoints of cellular resuscitation [65]. Recent data on tissue oxygen parameters also advise that these measures are promising markers of adequate restoration of perfusion [66]. The use of super normal delivery of oxygen has been proposed but a study conducted by McKinley and coworkers [67] demonstrated that levels of DO ₂ greater than 600 ml/min per one thousand^two are not warranted.

Determination

Hemorrhagic shock can be apace fatal. The primary goal is to stop the bleeding. Resuscitation may well depend on estimated severity of hemorrhage. It now appears that patients who accept moderate hypotension from moderate bleeding may well benefit from a delay in massive resuscitation in gild to accomplish a definitive care facility. On the other paw, when patients are obviously in astringent hemorrhagic shock, the apply of intravenous crystalloids or colloids and blood products when available can exist life saving. Uncertainties remain regarding the all-time method for resuscitation, what type of fluid, how much, when, and how fast [68].

A hemoglobin level of 7–8 g/dl is an advisable threshold for transfusion in critically ill patients with no risk factors for tissue hypoxia. Maintaining a hemoglobin level of 10 g/dl is a reasonable goal for patients who are actively bleeding, the elderly, or individuals at risk for a myocardial infarction. Moreover, hemoglobin concentration should not be the simply therapeutic guide in actively bleeding patients. Instead, therapy should be aimed at restoring intravascular volume and acceptable hemodynamic parameters.

Competing interests

None declared.

Abbreviations

CaO ₂ = arterial oxygen content; DO _two = oxygen commitment; EBV = estimated blood volume; 5O ₂ = oxygen consumption.

References

• Fink MP. Demote-to-bedside review: cytopathic hypoxia. Crit Care. 2002;vi:491–499. doi: 10.1186/cc1824. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
• Kasuya H, Onda H, Yoneyama T, Sasaki T, Hori T. Bedside monitoring of circulating blood volume later on subarachnoid hemorrhage. Stroke. 2003;34:956–960. doi: 10.1161/01.STR.0000064321.10700.63. [PubMed] [CrossRef] [Google Scholar]
• Cropp GJ. Changes in blood and plasma volumes during growth. J Pediatr. 1971;78:220–229. [PubMed] [Google Scholar]
• Committee on Trauma . Avant-garde Trauma Life Support Manual. Chicago: American College of Surgeons; 1997. pp. 103–112. [Google Scholar]
• Bourke DL, Smith TC. Estimating allowable hemodilution. Anesthesiology. 1974;41:609–612. [PubMed] [Google Scholar]
• Jolliet P, Thorens JB, Nicod L, Pichard C, Kyle U, Chevrolet JC. Relationship betwixt pulmonary oxygen consumption, lung inflammation, and calculated venous admixture in patients with acute lung injury. Intensive Intendance Med. 1996;22:277–285. doi: 10.1007/s001340050081. [PubMed] [CrossRef] [Google Scholar]
• Adachi H, Strauss W, Ochi H, Wagner NH. The upshot of hypoxia on the regional distribution of cardiac output in the canis familiaris. Circ Res. 1976;39:314–319. [PubMed] [Google Scholar]
• Ray CJ, Abbas MR, Coney AM, Marshall JM. Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies. J Physiol. 2002;544:195–209. doi: 10.1113/jphysiol.2002.023440. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
• Edmunds NJ, Marshall JM. Vasodilatation, oxygen commitment and oxygen consumption in rat hindlimb during systemic hypoxia: roles of nitric oxide. J Physiol. 2001;532:251–259. doi: 10.1111/j.1469-7793.2001.0251g.x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Schlichtig R, Kramer DJ, Pinsky MR. Flow distribution during progressive hemorrhage is a determinat of disquisitional O_ii delivery. J Appl Physiol. 1991;70:169–178. [PubMed] [Google Scholar]
• Vetterlein F, Schmidt G. Effects of propranolol and epinephrine on density of capillaries in rat centre. Am J Physiol. 1984;246:H189–H196. [PubMed] [Google Scholar]
• Krolo I, Hudetz AG. Hypoxemia alters erythrocyte perfusion pattern in the cerebral capillary network. Microvasc Res. 2000;59:72–79. doi: 10.1006/mvre.1999.2185. [PubMed] [CrossRef] [Google Scholar]
• Parthasarathi Chiliad, Lipowsky HH. Capillary recruitment in response to tissue hypoxia and its dependence on cerise claret cell deformability. Am J Physiol. 1999;277:H2145–H2157. [PubMed] [Google Scholar]
• Hepple RT, Hogan MC, Stary C, Bebout DE, Mathieu-Costello O, Wagner PD. Structural basis of muscle O₂ diffusing capacity: prove from musculus role in situ. J Appl Physiol. 2000;88:560–566. [PubMed] [Google Scholar]
• Cain SM. Peripheral oxygen uptake and delivery in health and affliction. Clin Breast Med. 1983;4:139–148. [PubMed] [Google Scholar]
• Schwartz S, Frantz RA, Shoemaker WC. Sequential hemodynamic and oxygen send responses in hypovolemia, anemia, and hypoxia. Am J Physiol. 1981;241:H864–H871. [PubMed] [Google Scholar]
• Nelson DP, King CE, Dodd SL, Schumacker PT, Cain SM. Systemic and intestinal limits of O₂ extraction in the canis familiaris. J Appl Physiol. 1987;63:387–394. [PubMed] [Google Scholar]
• Chapler CK, Cain SM. Circulatory adjustments to anemic hypoxia. Adv Exp Med Biol. 1988;227:103–115. [PubMed] [Google Scholar]
• Gutierrez G, Marini C, Acero AL, Lund N. Skeletal muscle PO₂ during hypoxemia and isovolemic anemia. J Appl Physiol. 1990;68:2047–2053. [PubMed] [Google Scholar]
• Weiskopf RB, Viele MK, Feiner J, Kelley Southward, Lieberman J, Noorani M, Leung JM, Fisher DM, Murray WR, Toy P, Moore MA. Human cardiovascular and metabolic response to acute, astringent isovolemic anemia. JAMA. 1998;279:217–221. doi: 10.1001/jama.279.3.217. [PubMed] [CrossRef] [Google Scholar]
• Lieberman JA, Weiskopf RB, Kelley SD, Feiner J, Noorani M, Leung J, Toy P, Viele MK. Disquisitional oxygen delivery in conscious humans is less than 7.3 ml O₂ × kg^-one × min^-one. Anesthesiology. 2000;92:407–413. doi: 10.1097/00000542-200002000-00022. [PubMed] [CrossRef] [Google Scholar]
• Hoppeler H, Vogt Yard. Muscle tissue adaptations to hypoxia. J Exp Biol. 2001;204:3133–3139. [PubMed] [Google Scholar]
• Lindqvist A, Dreja M, Sward Grand, Hellstrand P. Effects of oxygen tension on energetics of cultured vascular polish muscle. Am J Physiol Heart Circ Physiol. 2002;283:H110–117. [PubMed] [Google Scholar]
• Schumacker PT, Chandel Due north, Agusti AGN. Oxygen conformance of cellular respiration in hepatocytes. Am J Physiol Lung Prison cell Mol Physiol. 1993;265:L395–L402. [PubMed] [Google Scholar]
• Erecinska M, Silver IA. Tissue oxygenation and brain sensitivity to hypoxia. Respir Physiol. 2001;128:263–276. doi: 10.1016/S0034-5687(01)00306-1. [PubMed] [CrossRef] [Google Scholar]
• Dubin A, Estensoro E, Murias Thou, Canales H, Sottile P, Badie J, Barán M, Pálizas F, Laporte 1000, Rivas Díaz K. Effects of hemorrhage on gastrointestinal oxygenation. Intensive Care Med. 2001;27:1931–1936. doi: 10.1007/s00134-001-1138-9. [PubMed] [CrossRef] [Google Scholar]
• Oakes SA, Opferman JT, Pozzan T, Korsmeyer SJ, Scorrano Fifty. Regulation of endoplasmic reticulum Ca²⁺ dynamics past proapoptotic BCL-ii family members. Biochem Pharmacol. 2003;66:1335–forty. doi: x.1016/S0006-2952(03)00482-nine. [PubMed] [CrossRef] [Google Scholar]
• Boutilier RG. Mechanisms of cell survival in hypoxia and hypothermia. J Exp Biol. 2001;204:3171–3181. [PubMed] [Google Scholar]
• Gutierrez Chiliad. Cellular effects. In: Crystal RG, West JB, Weibel ER, Barnes PJ, editor. The Lung: Scientific Foundations. 2. New York: Raven Press Ltd; 1996. pp. 1969–1979. [Google Scholar]
• Warren JC. Surgical Pathology and Therapeutics. Philadelphia: Lea & Febiger; 1895. [Google Scholar]
• Shevell T, Malone FD. Management of obstetric hemorrhage. Semin Perinatol. 2003;27:86–104. [PubMed] [Google Scholar]
• Wolinsky PR. Assessment and management of pelvic fracture in the hemodynamically unstable patient. Orthop Clin North Am. 1997;28:321–329. [PubMed] [Google Scholar]
• Cannon WB, Fraser J, Cowell EM. The preventive treatment of wound shock. JAMA. 1918;lxx:618–621. [Google Scholar]
• Wiggers CJ. Physiology of Shock. New York: Democracy Fund; 1950. Irreversible shock; pp. 121–146. [Google Scholar]
• Shires T, Coln D, Carrico J, Lightfoot S. Fluid therapy in hemorrhagic shock. Arch Surg. 1964;8:688–693. [PubMed] [Google Scholar]
• Healey MA, Davis RE, Liu FC, Loomis WH, Hoyt DB. Lactated Ringers is superior to normal saline in a model of massive hemorrhage and resuscitation. J Trauma. 1998;45:894–898. [PubMed] [Google Scholar]
• Cochrane Injuries Group Albumin Reviewers Human albumin administration in critically ill patients:systematic review of randomized controlled trials. BMJ. 1998;317:235–240. [PMC free article] [PubMed] [Google Scholar]
• Choi PTL, Yip G, Quinonez LG, Melt DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med. 1999;27:200–210. doi: 10.1097/00003246-199901000-00053. [PubMed] [CrossRef] [Google Scholar]
• Hoyt D. Fluid resuscitation: the target from an assay of trauma systems and patient survival. J Trauma. 2003;Suppl:S31–S35. [PubMed] [Google Scholar]
• Schierhout Chiliad, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically sick patients: systematic review of randomised controlled trials. BMJ. 1998;316:961–964. [PMC gratis commodity] [PubMed] [Google Scholar]
• Wade CE, Grady JJ, Kramer GC, Younes RN, Gehlsen K, Holcroft JW. Private patient cohort analysis of the efficacy of HSD in patients with traumatic brain injury and hypotension. J Trauma. 1997;Suppl:S61–S65. [PubMed] [Google Scholar]
• Mattox KL, Maningas PA, Moore EE, Mateer JR, Marx JA, Aprahamian C, Burch JM, Pepe PE. Prehospital hypertonic saline/ dextran infusion for post-traumatic hypotension. The UsA. Multicenter Trial. Ann Surg. 1991;213:482–491. [PMC free article] [PubMed] [Google Scholar]
• Wade CE, Grady JJ, Kramer GC. Efficacy of hypertonic saline dextran fluid resuscitation for patients with hypotension from penetrating trauma. J Trauma. 2003;Suppl:S144–148. [PubMed] [Google Scholar]
• Creteur J, Sibbald Westward, Vincent JL. Hemoglobin solutions: non merely red blood jail cell substitutes. Crit Care Med. 2000;28:3025–3034. doi: 10.1097/00003246-200008000-00058. [PubMed] [CrossRef] [Google Scholar]
• Gould SA, Moore EE, Hoyt DB, Burch JM, Haenel JB, Garcia J, DeWoskin R, Moss GS. The first randomized trial of human polymerized hemoglobin every bit a blood substitute in acute trauma and emergency surgery. J Am Coll Surg. 1998;187:113–120. doi: x.1016/S1072-7515(98)00095-7. [PubMed] [CrossRef] [Google Scholar]
• Sloan EP, Koenigsberg M, Gens D, Cipolle 1000, Runge J, Mallory MN, Rodman G., Jr Diaspirin cantankerous-linked hemoglobin (DCLHb) in the handling of astringent traumatic hemorrhagic daze: a randomized controlled efficacy trial. JAMA. 1999;282:1857–1864. doi: 10.1001/jama.282.19.1857. [PubMed] [CrossRef] [Google Scholar]
• Singbartl K, Innerhofer P, Radvan J, Westphalen B, Chips D, Stogbauer R, Van Aken H. Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesth Analg. 2003;96:929–935. doi: 10.1213/01.ANE.0000052711.68903.5D. [PubMed] [CrossRef] [Google Scholar]
• Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napoliltano LM. Blood transfusion, independent of shock severity is associated with worse issue in trauma. J Trauma. 2003;54:898–907. [PubMed] [Google Scholar]
• Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts–claret transfusion. N Engl J Med. 1999;340:438–447. doi: ten.1056/NEJM199902113400606. [PubMed] [CrossRef] [Google Scholar]
• Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of 2 parts: blood conservation. Due north Engl J Med. 1999;340:525–533. doi: 10.1056/NEJM199902183400706. [PubMed] [CrossRef] [Google Scholar]
• Anonymous Consensus conference: perioperative red claret cell transfusion. JAMA. 1988;260:2700–2703. [PubMed] [Google Scholar]
• American Higher of Physicians Practice strategies for elective scarlet blood cell transfusion. Ann Intern Med. 1992;116:403–406. [PubMed] [Google Scholar]
• Anonymous Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Chore Force on Blood Component Therapy. Anesthesiology. 1996;84:732–747. [PubMed] [Google Scholar]
• Expert Working Grouping Guidelines for red claret jail cell and plasma transfusions for adults and children. CMAJ. 1997;Suppl 11:S1–S25. [Google Scholar]
• Lenfant C. Transfusion practice should exist audited for both undertransfusion and overtransfusion. Transfusion. 1992;32:873–874. doi: 10.1046/j.1537-2995.1992.32993110764.10. [PubMed] [CrossRef] [Google Scholar]
• Khanna MP, Hebert PC, Fergusson DA. Review of the clinical do literature on patient characteristics associated with allogeneic redblood cell transfusion. Transfus Med Rev. 2003;17:110–119. doi: 10.1053/tmrv.2003.50008. [PubMed] [CrossRef] [Google Scholar]
• Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello Thousand, Tweeddale K, Schweitzer I, Yetisir Due east. A multicenter, randomized, controlled clinical trial of transfusion requirements in disquisitional care. Due north Engl J Med. 1999;340:409–417. doi: 10.1056/NEJM199902113400601. [PubMed] [CrossRef] [Google Scholar]
• Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs Fifty, Webb A, Meier-Hellmann A, Nollet 1000, Peres-Bota D, ABC Investigators Anemia and Claret Transfusion in Critically Ill Patients. JAMA. 2002;288:1499–1507. doi: 10.1001/jama.288.12.1499. [PubMed] [CrossRef] [Google Scholar]
• Wu W-C, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with astute myocardial infarction. Due north Engl J Med. 2001;345:1230–1236. doi: 10.1056/NEJMoa010615. [PubMed] [CrossRef] [Google Scholar]
• Bickell WH, Wall MJ, Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331:1105–1109. doi: ten.1056/NEJM199410273311701. [PubMed] [CrossRef] [Google Scholar]
• Mapstone J, Roberts I, Evans P. Fluid resuscitation strategies: a systematic review of animal trials. J Trauma. 2003;55:571–589. [PubMed] [Google Scholar]
• Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-infirmary mortality. J Trauma. 2002;52:1141–1146. [PubMed] [Google Scholar]
• Innerhofer P, Chips D, Margreiter J, Klingler A, Kühbacher Chiliad, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger Westward. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot germination. Anesth Analg. 2002;95:858–865. doi: 10.1097/00000539-200210000-00012. [PubMed] [CrossRef] [Google Scholar]
• Porter JM, Ivatury RR. In search of the optimal end points of resuscitation in trauma patients: a review. J Trauma. 1998;44:908–914. [PubMed] [Google Scholar]
• Gutierrez Thou, Taylor D. Gastrointestinal tonometry: basic principles and recent advances in monitoring regional CO_two metabolism. Semin Respir Crit Care Med. 1999;20:17–27. [Google Scholar]
• McKinley BA, Parmley CL, Butler BD. Skeletal musculus pO2, pCO2, and pH in hemorrhage, shock and resuscitation in dogs. J Trauma. 1998;44:119–127. [PubMed] [Google Scholar]
• McKinley BA, Kozar RA, Cocanour CS, Valdivia A, Sailors RM, Ware DN, Moore FA. Normal versus supranormal oxygen delivery goals in shock resuscitation: the response is the dame. J Trauma. 2002;53:825–832. [PubMed] [Google Scholar]
• Kwan I, Bunn F, Roberts I, WHO Pre-Hospital Trauma Care Steering Committee Timing and book of fluid administration for patients with bleeding. Cochrane Database Syst Rev. 2003;3:CD002245. [PubMed] [Google Scholar]

gibsonamis1962.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1065003/

Share this post